Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.

Investlytic score: 3/5 criteria met.
- ✅ Price trend passed
- ✅ Growth passed
- ❌ Debt failed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): the price has been multiplied by at least 1.5.
Price change 2024 → 2025: 23.07%
Price change 2025 → 2026: 84.98%
Price change 2026 (year to date): 87.03%
Financial growth
Revenue CAGR (8 years): 37.81%
Earnings CAGR (8 years): 62.84%
Growth status: positive trend (>1%/yr) in revenue and earnings.
Debt
Debt-to-equity ratio: 8.10
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 24.58
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 9.34% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="MRX" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Marex Group plc Ordinary Shares | 22.4 | 8.10 | +21.3 % | 🔒 |
| Sezzle Inc. | 33.4 | 0.83 | +233.6 % | – |
| Axos Financial, Inc. | 10.7 | 0.14 | +21.8 % | ★ 5/5 |
| Ameris Bancorp | 12.9 | 0.18 | +18.0 % | ★ 5/5 |
| TeraWulf Inc. | – | 36.99 | +16.7 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by Marex Group Limited over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2020 | 758 m | 43.8 m | 5.8 % | n/a |
| 2021 | 852 m | 56.5 m | 6.6 % | +12.4 % |
| 2022 | 1.2 bn | 91.6 m | 7.8 % | +38.0 % |
| 2023 | 2.4 bn | 128 m | 5.4 % | +100.1 % |
| 2024 | 2.9 bn | 218 m | 7.5 % | +23.1 % |
| 2025 | 3.6 bn | 308 m | 8.5 % | +25.4 % |
Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.
Accounts and financial health
Balance sheet and cash flow published by Marex Group Limited over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and investments | 758 m | 3.2 bn | 4.7 bn | 5.2 bn | 13.5 bn |
| Total Debt | 1.3 bn | 5.7 bn | 5.4 bn | 6.1 bn | 10.2 bn |
| Net Debt | 578 m | 4.8 bn | 3.9 bn | 3.6 bn | 3.9 bn |
| Equity | 478 m | 678 m | 776 m | 977 m | 1.3 bn |
| Total assets | 5.3 bn | 15.7 bn | 17.6 bn | 24.3 bn | 34.7 bn |
| Operating cash flow | 471 m | 226 m | 735 m | 1.2 bn | 668 m |
| Investments (capex) | 7.3 m | 9.4 m | 9.0 m | 11.7 m | 19.8 m |
| Free cash-flow | 464 m | 216 m | 723 m | 1.1 bn | 654 m |
| Share buybacks | 0 | 7.9 m | 3.1 m | 19.8 m | 44.1 m |
| Dividends paid | 20.0 m | 6.6 m | 58.3 m | 77.1 m | 55.5 m |
Amounts in USD, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.
Valuation and competitors
Marex Group Limited compared with its sector on the same exchange and with its main competitors.
Direct competitors
| Company | Market cap (USD) | P/E | Net margin |
|---|---|---|---|
| Marex Group Limited | 4.8 bn | 22.4 | 8.5 % |
| StoneX Group Inc. SNEX | 6.6 bn | 13.0 | 0.2 % |
| BGC Group, Inc BGC | 4.9 bn | 8.4 | 5.2 % |
| MarketAxess Holdings Inc. MKTX | 5.8 bn | 21.3 | 29.0 % |
| Tradeweb Markets Inc. TW | 27.6 bn | 32.4 | 39.6 % |
| Cboe Global Markets, Inc. CBOE | 36.9 bn | 25.3 | 23.3 % |
| Nasdaq, Inc. NDAQ | 59.9 bn | 29.4 | 21.8 % |
| Jefferies Financial Group Inc. JEF | 9.0 bn | 12.8 | 6.6 % |
| Stifel Financial Corp SF | 10.7 bn | 12.1 | 10.9 % |
| Sector median (Nasdaq) | 20.6 |
Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 13/11/2026. Competitors: comparable companies named by the data provider.
Analyst consensus and forecasts
What the financial analysts covering Marex Group Limited publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Average target over the last 3 months: 84.00 USD (3 targets).
Track record against expectations: reported EPS above consensus 6 times over the last 6 releases.
Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.
Who owns the stock
Free float, institutional investors, large funds, executives and elected officials: declared positions in Marex Group Limited.
Large funds tracked
| Fund | Shares | Value (USD) | Weight in the fund | Change | Quarter |
|---|---|---|---|---|---|
| Fidelity | 5.4 m | 327 m | 0.0 % | +54.2 % | 2026Q2 |
| T. Rowe Price | 4.9 m | 300 m | 0.0 % | +158.3 % | 2026Q2 |
| BlackRock | 4.6 m | 280 m | 0.0 % | +4.7 % | 2026Q2 |
| State Street | 2.1 m | 125 m | 0.0 % | +135.1 % | 2026Q2 |
| Invesco | 1.4 m | 85.6 m | 0.0 % | +2.3 % | 2026Q2 |
| Two Sigma Investments | 1.3 m | 81.4 m | 0.1 % | -20.6 % | 2026Q2 |
| Morgan Stanley | 1.2 m | 71.3 m | 0.0 % | +145.1 % | 2026Q2 |
| Geode Capital Management | 897,253 | 52.9 m | 0.0 % | +23.5 % | 2026Q2 |
Latest insider transactions
| Date | Person | Side | Amount |
|---|---|---|---|
| 09/11/2026 | Tonucci Paolo | sale | 216,981 USD |
| 09/11/2026 | Tonucci Paolo | sale | 739,595 USD |
| 09/11/2026 | Tonucci Paolo | sale | 188,229 USD |
| 05/11/2026 | Van Den Born Simon | sale | 416,000 USD |
| 05/11/2026 | Van Den Born Simon | sale | 409,028 USD |
| 05/11/2026 | Van Den Born Simon | sale | 296,719 USD |
Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 16/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about Marex Group Limited
What is the Marex Group Limited share price?
Latest recorded price: 70.72 USD on 13/11/2026, for a market cap of 5.1 bn USD.
What is the revenue of Marex Group Limited?
3.6 bn USD for fiscal year 2025, with net income of 308 m USD (net margin 8.5 %).
What do analysts say about Marex Group Limited?
Out of 7 analysts: 7 buy or strong buy, 0 hold, 0 sell or strong sell. Average price target: 84.00 USD, i.e. +26.9 % from the share price.
What is the P/E ratio of Marex Group Limited?
Trailing 12-month P/E of 23.9, against 20.6 for the sector median on the same exchange (10-year median: 23.1).
Is Marex Group Limited stock eligible for the French PEA?
No: the company is headquartered outside the European Union and the European Economic Area (ISIN GB00BMT7GT62).
How many employees does Marex Group Limited have?
2,425 full-time employees according to the latest published profile.
Who runs Marex Group Limited?
Ian Theo Lowitt is the company's chief executive.
Which large funds own Marex Group Limited?
As of 2026Q2, among the large funds tracked: Fidelity, T. Rowe Price, BlackRock, State Street, Invesco.